Julien Bovet

International Medical Director
Novo Nordisk A/S, Søborg, Denmark
Søborg, Hovedstaden, Denmark

Presentation(s):

• OC 40.5 - Management of breakthrough bleeding episodes in the phase 3 concizumab studies

  Monday, June 24, 2024
  15:45 – 16:00 ICT